Dr. Vince Elected to the AHC Academy of Excellence in Health ResearchDr. Robert Vince, Director of Center for Drug Design and Professor of Medicinal Chemistry, has been elected to the Academic Health Center’s Academy of Excellence in Health Research. Inaugurated in 2003, the AHC Academy for Excellence in Health Research serves as the highest recognition of excellence in AHC faculty research. Honorees are chosen for their "many contributions to the quality of the University of Minnesota through sustained nationally and internationally recognized health-related research in his/her field”. Dr. Vince’s scientific contributions and eclectic approach to solving problems have focused on unique methods in the development of novel chemotherapeutic agents. His most notable achievement is the design of carbocyclic nucleosides agents, termed "carbovirs", that were later developed into the anti-HIV drug, ZiagenTM. It is marketed worldwide by GlaxoSmithKline for the treatment of AIDS in adults and children. Among Dr. Vince's many honors, he has been recognized on "Scholars Walk and Wall of Discovery" at the University of Minnesota in 2006 and was a 2007 American Chemical Society Division of Medicinal Chemistry Hall of Fame Inductee. NIH Awards Dr. Duckworth FellowshipCongratulation to Dr. Benjamin Duckworth, in Courtney Aldrich's lab. He has been awarded a two-year fellowship by the National Institute of Allergy and Infectious Diseases for "Investigation of tuberculosis adenylating enzymes using activity probes." Dr. Kamberaj Wins First Prize for Best PosterCongratulation to Dr. Hiqmet Kamberaj, in Yuk Sham's lab. He has received the First Prize for his poster at the "Bioinformatics: Building Bridges Symposium." His poster was entitled "Computational Alanine Scanning of the Beta Lactamase Inhibitor Protein and TEM-1 Beta-Lactamase Complex." NIH Awards Development of Cyanide Antidote GrantSteven Patterson, Ph.D. (Center for Drug Design), has been awarded a three-year, $3.5 million grant from the National Institute of Neurological Disorders and Stroke. This is a second NIH grant based upon his continuing research involving the development of a drug against cyanide poisoning. Dr. Wang Wins First Place Poster AwardWe are pleased to announce that Center for Drug Design member, Professor Zhengqiang Wang, has won the 1st Place Poster Award in the category of "Young Investigator" at the 21st International Conference on Antiviral Research in Montreal, Canada. In addition, he was selected to give an oral "shotgun" presentation to the conference attendees because of this award. The title of the poster and talk was "From RT Inhibitors to RT/IN Dual Inhibitors: A Rational Design". | Upcoming Seminar: Michael Jung on Feb 3Please join us at 10:30 AM at 2-520 Moos Tower, for a seminar by Prof. Michael Jung, Department of Chemistry and Biochemistry, UCLA. His talk is entitled "Development of new methods for the preparation of hindered cyclohexane systems and treating prostate cancer: a synthetic chemist's attempt." Light refreshments will be available.
CDD Seminar Schedule
Upcoming Event: |
